Cryo-Save logo CryoSave

overview

News & Events

global
March 17, 2015

ESPERITE financial results for 2014 published, metamorphosis completed, first positive forecast growth at €36mio Revenues (+30%) for 2015

PRESS RELEASE

 

Zutphen, The Netherlands – 17 March 2015

 

ESPERITE (“Esperite N.V. (Euronext: ESP, “ESPERITE” or “the Company”) strengthens market position of Genoma with acquisitions of exclusive technologies for fully-certified groundbreaking genetic tests.

 

Stem cell historical CryoSave’s core business now profitable and improving.

 

Consolidated operations, headcount rationalization, integrated sales and marketing strategies, laboratories integration and processes automatization completed to yield enhanced performance and results.

global
February 23, 2015

ESPERITE pioneers first treatment worldwide of Cerebral Palsy using two types of stem cells

PRESS RELEASE

 

Geneva, Switzerland – 23 February 2015

 

CryoSave, part of ESPERITE, is the only private cord blood bank sponsoring a GCP clinical trial according to GMP-ATMP international guidelines

 

CryoSave leads and sponsors a multicentre clinical trial following GCP-ICH standards, for investigation of new treatment of Cerebral Palsy using dual infusion of two types of stem cells derived from umbilical cord blood and cord tissue processed by CryoSave

Cryo-Save
global
June 30, 2014

Secondary listing Euronext Paris starts 7 July 2014, name change to Esperite N.V

PRESS RELEASE

Zutphen, the Netherlands, 30 June 2014

Cryo-Save Group N.V.

Secondary listing Euronext Paris starts 7 July 2014, name change to Esperite N.V scheduled for 2 July 2014

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell processing and cryo-conservation company and the largest family stem cell bank in Europe announces today that its secondary listing on Euronext Paris shall become effective 7 July 2014 and that in relation to the secondary listing a summary document has been published today and is available on the company's website – www.cryo-save.com/group.

global
June 19, 2014

Cryo-Save Group N.V. Board Change

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, announces today that Mr. Walter van Pottelberge shall step down and resign as non-executive board member effective 30 June 2014.

  1. 1
  2. 2
  3. 14
  4. 15
  5. 16
  6. 28
  7. 29